PHIL® Embolic System Pediatric IDE
NCT: NCT03731000 · RECRUITING
Brief Summary
The purpose of this study is to collect information about how the PHIL® Embolic System works in the treatment of intracranial dural arteriovenous fistulas. Data collected in this study will be used to evaluate the safety and probable benefits in treating DAVFs. The PHIL® Embolic System is a Humanitarian Use Device (HUD). The U.S. Food and Drug Administration (FDA) approved the use of the PHIL Embolic System as a HUD in June 2016.
Frequently Asked Questions
What is PHIL® Embolic System Pediatric IDE?
PHIL® Embolic System Pediatric IDE is a clinical trial registered under NCT03731000. Current status: RECRUITING.
What is the status of NCT03731000?
The current status of NCT03731000 (PHIL® Embolic System Pediatric IDE) is: RECRUITING.
When did PHIL® Embolic System Pediatric IDE start?
PHIL® Embolic System Pediatric IDE started on 2019-04-16.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.